The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Down so long that it looks like up to me. Don't get me wrong - I don't think there is a great long term investment thesis on this one, but at some point the ugliness in the Chinese small cap market has to stop - and when it does, a profitable small company with a clean balance sheet should be worth something. If this stock goes up 10 cents it will beat the market over the next year in terms of a percentage move.
I have felt just that way for awhile myself. If one looks at the change from 50 day m/a on most of these China companies now (7/17), I believe the naysayers might be very surprised. I'm re-adding it today. Not ALL the Chinese are crooked. As a matter of fact, I'd prefer to bet on the avg. China businessman for honesty than his American counterpart.